Free shipping on all orders over $ 500

 About 1 result found for searched term "Vandortuzumab vedotin" (0.128 seconds)

Cat.No.  Name Target
M24699 Vandortuzumab vedotin Antibody-Drug Conjugates (ADCs)
DSTP 3086S; RG 7450; MSTP2109A
Vandortuzumab vedotin (DSTP 3086S) is an antibody-drug-conjugate to target prostate cancer.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.